NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Zhejiang Doer Biologics Co., Ltd.

Zhejiang Doer Biologics Co., Ltd.

Private
HangzhouHealthcare & Life Scienceshttps://doerbio.com/

Last Round

M&A

Apr 27, 2021

Est. Valuation

$99.65M

Total Funding Raised

$22.29M

Company Overview

Zhejiang Doer Biologics Co., Ltd. is a biopharmaceutical company that focuses on the discovery and development of multi-domain based multi-specific biotherapeutics to address unmet medical needs in the field of metabolic diseases and cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalmulti-specific proteinprotein engineeringbiotechmetabolic diseaseoncologydrug discoveryantibody therapyVHH-based biotherapeutichalf-life extensionprecision medicinedrug licensingbiologicsclinical-stage biotechR&D partnership

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zhejiang Doer Biologics Co., Ltd. Comparables

Compare Zhejiang Doer Biologics Co., Ltd. with similar companies based on industry and business-model similarity.

Zhejiang Doer Biologics Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gmax Biopharm
79%
Sciwind Biosciences
78%
89bio, Inc.
77%

Zhejiang Doer Biologics Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AApr 27, 2021
Series A ExtensionNov 2, 2020
Series AFeb 13, 2019
Corporate FundingJul 30, 2016

Key People

Founding team and executive leadership

Yan-shan Huang

CEO

Executive Team

Zhejiang Doer Biologics Co., Ltd. Investors

Notable investors and investment history

Zhejiang Doer Biologics Co., Ltd. investors
InvestorRounds
Zhejiang Sino Wisdom Investment ManagementSeries A Extension
Kaitai CapitalSeries A, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 6, 2025

    Monthly visitors increased 1062% MoM, reaching 988.

  • Jul 30, 2016

    Raised $3M in a corporate funding round.

Zhejiang Doer Biologics Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zhejiang Doer Biologics Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zhejiang Doer Biologics Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range7
Year Founded2014
Last FundingApr 27, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.